Skip to content
10-Q

Quarterly Report

PAVmed Inc. PAVM

0001437749-26-017121

← back to feed
Filed
May 14, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 12, 2026 7.27M sh
Shares Diluted Q1 2026 · Mar 31, 2026 1.58M sh
Shares Diluted restated Q1 2026 · Mar 31, 2025 1.75M sh
Capex Q1 2026 · Mar 31, 2026 $22K
Capex Q1 2026 · Mar 31, 2025 $6K
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$2.62M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$1.58M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $6.46M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $1.54M
Stockholders Equity Q1 2026 · Mar 31, 2026 $39.52M
Stockholders Equity Q1 2026 · Dec 31, 2025 $33.97M
Current Liabilities Q1 2026 · Mar 31, 2026 $3.66M
Current Liabilities Q1 2026 · Dec 31, 2025 $14.84M
Total Liabilities Q1 2026 · Mar 31, 2026 $20.43M
Total Liabilities Q1 2026 · Dec 31, 2025 $16.51M
Current Assets Q1 2026 · Mar 31, 2026 $7.41M
Current Assets Q1 2026 · Dec 31, 2025 $2.56M
Total Assets Q1 2026 · Mar 31, 2026 $45.42M
Total Assets Q1 2026 · Dec 31, 2025 $38.81M
Eps Diluted Q1 2026 · Mar 31, 2026 −$4.42
Eps Diluted restated Q1 2026 · Mar 31, 2025 $10.10
Eps Basic Q1 2026 · Mar 31, 2026 −$4.42
Eps Basic restated Q1 2026 · Mar 31, 2025 $38.26
Sga Expense Q1 2026 · Mar 31, 2026 $6.36M
Sga Expense Q1 2026 · Mar 31, 2025 $4.38M
Rd Expense Q1 2026 · Mar 31, 2026 $1.39M
Rd Expense Q1 2026 · Mar 31, 2025 $787K
Net Income Q1 2026 · Mar 31, 2026 −$60K
Net Income Q1 2026 · Mar 31, 2025 $18.97M
Operating Income Q1 2026 · Mar 31, 2026 −$8.04M
Operating Income Q1 2026 · Mar 31, 2025 −$5.45M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $97K
Cost Of Revenue Q1 2026 · Mar 31, 2025 $36K
Revenue Q1 2026 · Mar 31, 2026 $22K
Revenue Q1 2026 · Mar 31, 2025 $8K